US Surgical completes Valleylab acquisition and boosts research and development
This article was originally published in Clinica
Net income for US Surgical in the first-quarter was $25 million, compared with $30 million in the previous quarter, despite a growth in sales of 11% to reach $317 million. During the quarter the company completed the integration of Valleylab, which it bought from Pfizer. US Surgical claims the acquisition has positioned it as the world leader in electrosurgical and ultrasonic product sales.